Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Florida
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Florida
11 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Florida.
Cities in Florida
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Healthcare Innovations Institute Inc, Coral Springs
- ALS Center at the University of Miami, Miami
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Homestead Associates in Research Inc, Homestead
- Visionary Investigators Network, Miami
- University of South Florida, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Gables Neurology, Miami
- Aqualane Clinical Research, Naples
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Nova Clinical Research - Bradenton- Site Number : 8400044, Bradenton
- Research by Design, LLC- Site Number : 8400053, Miami Lakes
- AdventHealth Orlando- Site Number : 8400006, Orlando
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Quantix Research, Miami
- USF Health - Morsani Center for Advanced Healthcare, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06752356Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1603, Maitland
- Site Number - 1606, Miami
- Site Number - 1617, Ormond Beach
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07032662A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 109, Coral Springs
- GC2402 Study Site 103, Port Charlotte
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Maitland
- Clinical Study Site, Tampa
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- UF Health Neurology - Jacksonville, Jacksonville
- Visionary Investigators Network, Miami
- University of South Florida, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Neurology Associates, Maitland
- Knight Neurology, Rockledge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Nova Clinical Research, LLC, Bradenton
- Suncoast Neuroscience Associates, Inc., St. Petersburg
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06538064From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.